Zurcher Kantonalbank (Zurich Cantonalbank) Ocular Therapeutix, Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 34,741 shares of OCUL stock, worth $258,125. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,741

Previous 31,981 8.63%

Holding current value

$258,125

Previous $278,000 6.47%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$8.33 - $11.47 $22,990 - $31,657	2,760 Added 8.63%	34,741 $296,000
Q3 2024 Nov 07, 2024	SELL	$6.45 - $9.23 $406 - $581	-63 Reduced 0.2%	31,981 $278,000
Q2 2024 Jul 29, 2024	BUY	$4.2 - $8.69 $118,897 - $246,005	28,309 Added 757.94%	32,044 $219,000
Q1 2024 Apr 25, 2024	BUY	$3.85 - $10.93 $14,379 - $40,823	3,735 New	3,735 $33,000
Q2 2022 Aug 09, 2022	SELL	$3.01 - $5.22 $24,212 - $41,989	-8,044 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$4.83 - $7.35 $12,625 - $19,212	-2,614 Reduced 24.53%	8,044 $40,000
Q4 2021 Feb 01, 2022	SELL	$6.16 - $12.07 $1,669 - $3,270	-271 Reduced 2.48%	10,658 $74,000
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $106 - $157	11 Added 0.1%	10,929 $109,000
Q2 2021 Jul 30, 2021	BUY	$13.43 - $19.16 $3,397 - $4,847	253 Added 2.37%	10,918 $155,000
Q1 2021 May 03, 2021	BUY	$15.82 - $22.11 $11,501 - $16,073	727 Added 7.32%	10,665 $175,000
Q4 2020 Jan 28, 2021	BUY	$7.91 - $22.95 $78,609 - $228,077	9,938 New	9,938 $206,000

Others Institutions Holding OCUL

# of Institutions

181

Shares Held

136M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $572M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Ocular Therapeutix, Inc Transaction History